Breaking News

eureKING, Skyepharma Partner to Build a New European Bio-CDMO Biz

Aims to address specific needs of companies dedicated to the production and manufacturing of biopharmaceuticals for other companies in the healthcare sector.

eureKING, a special purpose acquisition company in healthcare dedicated to bioproduction, has submitted an offer to acquire Skyepharma, a contract development and manufacturing company (CDMO) involved in innovation and development in drug development and delivery of oral technologies. eureKING would remain listed on the Professional Segment of Euronext Paris following the completion of the transaction. With the support of eureKARE SA, a specialized company in creating, financing, and supporti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters